Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy

European Heart Journal

Volumn 29, Issue 9, 2008, Pages 1160-1167

  Östman Smith, Ingegerd ^a   Wettrell, Göran ^b   Keeton, Barry ^c   Holmgren, Daniel ^a   Ergander, Ulf ^d   Gould, Steven ^e   Bowker, Colene ^e   Verdicchio, Mario ^f  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f Department of Forensic Chemistry and Genetics   (Sweden)

Author keywords

Familial hypertrophic cardiomyopathy; Gender; Hypertrophic cardiomyopathy; Mortality; Screening; Sudden death

Indexed keywords

ADULT; AORTA STENOSIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE REGISTRY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYOCARDITIS; PRIORITY JOURNAL; SEX DIFFERENCE; SUDDEN DEAFNESS;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGE DISTRIBUTION; AGE FACTORS; ANDROGENS; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SEX FACTORS; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 45349098461     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn122     Document Type: Article

References (39)

1. Hada Y, Sakamoto T, Amano K, Yamaguchi T, Takenaka K, Takahashi H, Takikawa R, Hasegawa I, Takahashi T, Suzuki J et al. Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening. Am J Cardiol 1987;59:183-184.
2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995;92:785-789.
3. Sugishita Y, Matsuda M, Iida K, Koshinaga J, Ueno M. Sudden cardiac death at exertion. Jpn Circ J 1983;47:562-572.
4. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.
5. Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela AL, Tikanoja T, Paavilainen T, Simell O. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol 1997;146:385-393.
6. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-538.
7. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999;281:650-655.
8. Östman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 1999;34:1813-1822.
9. Semsarian C, French J, Trent RJ, Richmond DR, Jeremy RW. The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy. Aust NZ J Med 1997;27:51-58.
10. Maron BJ, Thompson PD, Puffer JC, McGrew CA, Strong WB, Douglas PS, Clark LT, Mitten MJ, Crawford MH, Atkins DL, Driscoll DJ, Epstein AE. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-856.
11. Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 2000;31:988-998.
12. Östman-Smith I, Wettrell G, Keeton B, Riesenfeld T, Holmgren D, Ergander U. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 2005;15:632-642.
13. Wisten A, Forsberg H, Krantz P, Messner T. Sudden cardiac death in 15-35-year olds in Sweden during 1992-99. J Intern Med 2002; 252:529-536.
14. Östman-Smith I, Devlin AM. A simple method for assessing the regression or progression of ventricular hypertrophy in the growing child and adult: the value of left ventricular wall-to-cavity ratios. Eur J Echocardiogr 2001;2:22-30.
15. Nugent A, Daubeney P, Chondros P, Carlin J, Colan S, Cheung M, Davis A, Chow C, Weintraub R. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 2005;112:1332-1338.
16. Motulsky H. Intuitive Biostatistics. New York: Oxford University Press, 1995.
17. Ackerman M, VanDriest S, Ommen S, Will M, Nishimura R, Tajik A, Gersh B. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and Troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol 2002;39:2042-2048.
18. Wren C, O'Sullivan JJ, Wright C. Sudden death in children and adolescents. Heart 2000;83:410-413.
19. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 2007; 115:773-781.
20. Ilondo MM, Vanderschueren-Lodeweyckx M, Vlietinck R, Pizarro M, Malvaux P, Eggermont E, Eeckels R. Plasma androgens in children and adolescents. Part I: control subjects. Horm Res 1982;16:61-77.
21. Persson I, Ahlsson F, Ewald U, Tuvemo T, Quingyuan M, von Rosen D, Proos L. Influence of perinatal factors on the onset of puberty in boys and girls. implications for interpretation of link with risk of long term diseases. American Journal of Epidemiology 1999;150:747-755.
22. Emery MJ, Krous HF, Nadeau-Manning JM, Marck BT, Matsumoto AM. Serum testosterone and estradiol in sudden infant death. J Pediatr 2005;147:586-591.
23. Fineschi V, Baroldi G, Monciotti F, Paglicci Reattelli L, Turillazzi E. Anabolic steroid abuse and cardiac sudden death: a pathologic study. Arch Pathol Lab Med 2001;125:253-255.
24. Kennedy MC, Lawrence C. Anabolic steroid abuse and cardiac death. Med J Aust 1993;158:346-348.
25. Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci 2000;45:16-23.
26. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 2001;50:399-408.
27. Lear-Kaul KC, Coughlin L, Dobersen MJ. Sudden unexpected death in epilepsy: a retrospective study. Am J Forensic Med Pathol 2005;26:11-17.
28. Hodgkinson KA, Parfrey PS, Bassett AS, Kupprion C, Drenckhahn J, Norman MW, Thierfelder L, Stuckless SN, Dicks EL, McKenna WJ, Connors SP. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005;45:400-408.
29. Francis J, Antzelevitch C. Brugada syndrome. Int J Cardiol 2005;101: 173-178.
30. Schwartz PJ, Spazzolini C, Crotti L, Bathen J, Amlie JP, Timothy K, Shkolnikova M, Berul CI, Bitner-Glindzicz M, Toivonen L, Horie M, Schulze-Bahr E, Denjoy I. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006;113:783-790.
31. James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol 2005;94:265-319.
32. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, Vicentini A, Spazzolini C, Nastoli J, Bottelli G, Folli R, Cappelletti D. Risk stratification in the long-QT syndrome. N Engl J Med 2003;348: 1866-1874.
33. Yetman AT, Hamilton RM, Benson LN, McCrindle BW. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol 1998;32: 1943-1950.
34. Yi G, Poloniecki J, Dickie S, Elliott PM, Malik M, McKenna WJ. Is QT dispersion associated with sudden cardiac death in patients with hypertrophic cardiomyopathy? Ann Noninvasive Electrocardiol 2001;6:209-215.
35. Rosengren A, Spetz CL, Koster M, Hammar N, Alfredsson L, Rosen M. Sex differences in survival after myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register. Eur Heart J 2001;22:314-322.
36. Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, Spataro A, Biffi A, Granata M, Maron BJ. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 2006;27:2196-2200.
37. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-1601.
38. Maron BJ, Seidman JG, Seidman CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;44:2125-2132.
39. Devlin AM, Ostman-Smith I. Diagnosis of hypertrophic cardiomyopathy and screening for the phenotype suggestive of gene carriage in familial disease: a simple echocardiographic procedure. J Med Screen 2000;7:82-90.